The COVID-19 crisis has intensified the debate over big data and privacy. Governments are pulling together data from public and private systems in order to predict and counter the spread of COVID-19. But setting aside privacy protections in a time of crisis could lead to new, permanent norms.
Companies often purchase competitors, not to acquire their ideas and products, but to shut them down. A recent report raised questions about whether such an acquisition may be partially responsible for a shortage of ventilators in the United States.
As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.
A greater share of Americans filed for unemployment insurance in the week ending March 21 than in any prior week in American history. We asked Yale SOM's Paul Goldsmith-Pinkham for his perspective on this alarming statistic.
What will the sudden economic shock mean for competition and antitrust policy? We asked Yale SOM’s Fiona Scott Morton, an economist who served in the Antitrust Division of the U.S. Department of Justice, for her perspective.
The stock markets are reeling as fear and uncertainty about the global pandemic grow. We asked Yale SOM’s William Goetzmann, whose research includes financial history, to put the volatility into historical perspective.
We asked Yale SOM’s Nathan Novemsky, an expert in the psychology of judgment and decision-making, for his thoughts on how consumers are behaving during the COVID-19 pandemic and how they’re likely to view companies’ actions in the aftermath.
Yale SOM’s Saed Alizamir, with Francis de Véricourt of ESMT and Shouqiang Wang of the University of Texas at Dallas, recently published a study that uses game theory to play out the tradeoffs that the WHO and other public agencies face as they try to give timely warnings while maintaining their credibility.